SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-008367
Filing Date
2020-02-11
Accepted
2020-02-11 17:01:12
Documents
2
Period of Report
2020-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1674
2 POA DOCUMENT poa.txt EX-24.3_893749 3592
  Complete submission text file 0001209191-20-008367.txt   6746
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MILLENDO THERAPEUTICS, INC. 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address
Arbet-Engels Christophe (Reporting) CIK: 0001802615 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35890 | Film No.: 20597909